Recently c-Cbl has been reported to be phosphorylated upon CSF-1 stimulation. The product of the c-cbl protooncogene (c-Cbl) is a 120 kDa protein harboring several docking sites for Src homology 2 (SH2) domain containing proteins and proline-rich regions that have been shown to allow its constitutive association with the SH3 domains of Grb2. We demonstrate here that CSF-1 exposure of stable transfectant CHO cells expressing the CSF-1 receptor induced the sustained tyrosine phosphorylation of c-Cbl and its subsequent association with Crk-II and the p85 kDa subunit of the PI 3-kinase, while it constitutively associates with Grb2. We demonstrate by in vitro experiments that these associations require the SH2 domain of Crk-II and both the C-and N-terminal SH2 domains of the p85 subunit of the PI 3-kinase. cCbl is the major PI 3-kinase-containing protein in c-Fms expressing CHO cells upon CSF-1 stimulation. Thus cCbl behaves as a core protein, allowing the formation of a quaternary complex including, Crk-II, PI 3-kinase and Grb2. We provide evidence that this multiprotein complex can interact with the tyrosine phosphorylated CSF-1 receptor through the unoccupied SH2 domain of Grb2.
Introduction
The Macrophage Colony Stimulating Factor (M-CSF) or Colony Stimulating Factor-1 (CSF-1) induces proliferation, dierentiation and survival of cells of the monocytic lineage (Sherr, 1990) . The CSF-1 receptor (CSF-1R), encoded by the c-fms proto-oncogene, is a transmembrane protein of 150 ± 170 kDa exhibiting an extracellular ligand binding domain, a hydrophobic transmembrane domain and an intracellular tyrosine kinase domain divided into two halves by a kinase insert segment (reviewed in Wai-Mun Lee, 1992) . Upon CSF-1 binding, the receptor dimerizes, leading to the activation of its intrinsic tyrosine kinase that results in autophosphorylation of the CSF-IR and phosphorylation of several cellular substrates. Several docking sites of the human CSF-1R have been identi®ed that can accommodate various transduction proteins such as Src-like kinases on Tyr 809, phosphatidylinositol 3-kinase (PI 3-kinase) on Tyr 723 or Grb2 on Tyr 699 (Reviewed in Stanley, 1994) .
Recently, CSF-1 has also been shown to induce the phosphorylation of the cytoplasmic c-Cbl which is the cellular homologue of the viral oncogene product v-cbl (Langdon et al., 1989; Tanaka et al., 1995; Wang et al., 1996) . v-cbl has been shown to induce preB lymphomas and myelogenous leukemias, while the cellular homologue does not have this capacity, even when it is overexpressed. This is probably due to a truncation of 60% of the C-terminal region of the proto-oncogene product which confers to v-Cbl the ability to migrate to the nucleus and to bind DNA, which is not the case for c-Cbl (Blake et al., 1993) . Owing to the transforming activity of v-Cbl, it has been suggested that c-Cbl may play a signi®cant role in the control of proliferation.
c-Cbl is a 120 kDa protein containing a proline-rich region allowing its interaction with SH3 domaincontaining proteins and several putative docking sites for a wide variety of SH2 domain-containing proteins. Recently, c-Cbl has been reported to be highly phosphorylated upon stimulation through T cell receptor (TCR) (Donovan et al., 1994) , B cell receptor (BCR) , Fcg receptor , granulocyte macrophage-colony stimulating factor receptor (GM-CSFR) and erythroprotein receptor (EPOR) (Odai et al., 1995) . These data strongly suggest that c-Cbl is likely to play a major role in the events occurring downstream of hematopoietic receptors coupled to c-Src-like kinases. However, its implication is not restricted to pathways controlled by non-receptor tyrosine kinases, since c-Cbl was recently shown to be also phosphorylated by Epidermal Growth Factor Receptor (EGFR) (Birge et al., 1992) and platelet derived growth-factor receptor (PDGF-R) (Galisteo et al., 1995) . Consistent with the structure of c-Cbl, it has been shown that c-Cbl could bind to transducing molecules such as Lck, Fyn (Reedquist et al., 1994) , Syk, the p85 subunit of the PI 3-kinase, Shc , Nck (Rivero-Lezcano et al., 1994) , Zap-70 (Fournel et al., 1996) , Grb2 (Motto et al., 1994) , Crk-II and the guanine nucleotide exchange factor C3G .
Given the numerous putative tyrosine phosphorylation sites present in c-Cbl, and hence the variety of possible tyrosine kinases phosphorylation patterns, we examined the pattern of transduction proteins that were selectively recruited to c-Cbl upon CSF-1 stimulation. Here, we show that, c-Cbl interacts (1) with the SH2 domains of both PI 3-kinase and Crk-II upon CSF-1 stimulation, and (2) constitutively with the SH3 domain of Grb2 through its proline rich region. Grb2, via its SH2 domain, can then join this multiprotein complex to the activated CSF-1R. Whereas multimolecular complexes involving c-Cbl with some transducing molecules have been described upon EGF and BCR stimulation Smit et al., 1996) , we provide the ®rst evidence that CSF-1 induces the formation of a multimeric complex involving Crk-II, c-Cbl, PI 3-kinase, Grb2 and CSF-1R.
Results
c-Cbl is phosphorylated on tyrosine residues upon CSF-1 stimulation and associates constitutively with Grb2 CSF-1 signaling was examined in this study using, as biological model, stable CHO transfectants expressing approximately 3610 3 CSF-1 receptors per cell (cFmsCHO) (data not shown). c-FmsCHO cells were exposed to CSF-1 for various periods of time before being lysed. The lysates were then subjected to SDS ± PAGE and processed for anti-phosphotyrosine (anti-PY) immunoblotting. As shown in Figure 1a , lanes 1 ± 5, CSF-1 induced the transient tyrosine phosphorylation of a number of proteins displaying apparent molecular weights of 170, 150, 120, 44 and 42 kDa, respectively. p150 has been previously identi®ed as the activated CSF-1R while p42-44 likely corresponded to the two isoforms of the Mitogen Activated Protein kinases (MAP-kinases) (Wai-Mun Lee, 1992) . We identi®ed p120 kDa protein as c-Cbl by immunoprecipitation with speci®c antibodies (Figure 1a , lanes 7 ± 10). A low tyrosine phosphorylation level of Cbl was largely enhanced within the minute following CSF-1 stimulation before slowly declining. Anti-c-Cbl reprobing of immunoblots ( Figure 1b , lanes 6 ± 10) con®rmed that the same amounts of c-Cbl were loaded in each lanes.
It has been reported that Grb2 can interact with activated CSF-1R (Van Der Geer and Hunter, 1993) , but also with the proline-rich motif of the C-terminal domain of c-Cbl (Donovan et al., 1994; RiveroLezcano et al., 1994) . We thus investigated whether Grb2 could interact both with c-Cbl and the CSF-1R upon CSF-1 stimulation. In that purpose c-FmsCHO cells were lysed after exposure to CSF-1 for various periods of time. Cell lysates were then subjected to immunoprecipitation with anti-Grb2 antibodies. Analysis of anti-Grb2 immunoprecipitations by anti-Py Western blotting revealed that two phosphoproteins of 120 and 150 kDa were coprecipitated with Grb2 ( Figure 1a , lanes 11 ± 15). The 150 kDa phosphoprotein likely corresponded to CSF-1R (data not shown), according to previous results (Van Der Geer and Hunter, 1993) . The 120 kDa phosphotyrosyl protein present in anti-Grb2 immunoprecipitates comigrates with the tyrosine phosphorylated band present in antic-Cbl immunoprecipitates and likely corresponded to cCbl, since in both the anti-c-Cbl and anti-Grb2 precipitates, the 120 kDa tyrosine-phosphorylated protein immunoreacted with anti-c-Cbl antibodies ( Figure 1b (Buday et al., 1996) or in BCR/ABL transformed chronic myelogenous leukemia (Sattler et al., 1996) . When Crk-II was immunoprecipitated from lysates from CSF-1-stimu- (7) or stimulated for 5 min (+) with CSF-1 were untreated (lanes 1 ± 6) or boiled for 5 min in 1% SDS containing LB (lanes 7 and 8), diluted 10 times and precipitated with either 30 mg GST-Crk-SH3 (lanes 1 and 2) or with GST-Crk-SH2 fusion protein precoupled onto glutathione-Sepharose beads (lanes 3 ± 8). GST-Crk-SH2-bound proteins were eluted in LB containing 10 mM fresh glutathione and then subjected to a second immunoprecipitation with anti-c-Fms antibodies (lanes 5 and 6). Precipitated proteins were resolved by SDS ± PAGE and analysed by immunoblotting with biotinylated anti-PY antibody (a) (Anti-PY). (b) Showed a typical result obtained after reprobing the membrane with anti-Grb2 antibodies (100 ng/ml). The positions of molecular mass markers are indicated on the left. The blots were visualized by chemiluminescence
Involvement of c-Cbl in CSF-1 signaling pathways H Husson et al the GST-Crk-SH2 fusion protein was no more able to precipitate any phosphoprotein of Mr 120 kDa (data not shown). The 150 kDa phosphotyrosyl protein comigrated with the immunopuri®ed activated CSF-1R (data not shown), but anti-c-Fms Western blotting failed to detect any signi®cant amount of CSF-1R, probably due to the limited sensitivity of the assay (data not shown). Identi®cation of the p150 kDa phosphorylated protein as CSF-1R was obtained by subjecting sequentially GST-Crk-SH2 bound proteins to a two step procedure. First, precipitated proteins were eluted with glutathione, and immunoprecipitated thereafter with anti-c-Fms antibodies. Using this strategy we could demonstrate that Crk-II formed a complex with activated CSF-1R (Figure 3a , lane 6). We next examined whether Crk-II was bound directly to CSF-1R by boiling cell lysates from resting or CSF-1-stimulated c-FmsCHO in 1% SDS to dissociate preformed complexes, diluting them tenfold in LB and then incubating them with GST-Crk-SH2 fusion protein. As shown in Figure 3a , lane 8, the anti-PY immunoblot showed that SDS treatment had no eect on the binding of c-Cbl to GST-Crk-SH2 domain, while the interaction between CSF-1R and Crk-II was disrupted. These results are consistent with the involvement of a docking protein which could link the activated CSF-1R to the phosphorylated c-Cbl.
Grb2 connects the c-Cbl/Crk-II complex to the activated CSF-1R
In as much as (1) the human CSF-1R harbors the consensus sequence responsible for the docking of the Grb2-SH2 domain on Tyr 699 (Van Der Greer and Hunter, 1993) , and (2) it has been shown that the SH3 domain of Grb2 associated constitutively to the prolinerich region of c-Cbl (Odai et al., 1995) , we considered the possibility that Grb2 might bridge the CSF-1R and the cCbl/Crk-II complex. Lysates from unstimulated or CSF-1-stimulated c-FmsCHO cells, untreated or boiled in 1% SDS were diluted tenfold in LB then precipitated with GST-Crk-SH2 and ®nally reprobed with anti-Grb2 antibodies. As shown in Figure 3b , lanes 7 and 8, the interaction between Grb2 and c-CblCrk-II was disrupted by SDS treatment. This supports the idea that c-Cbl nucleates the formation of a multiprotein complex including Crk-II and Grb2, which then becomes associated to CSF-1R upon CSF-1 stimulation, via the free SH2 domain of Grb2.
PI 3-kinase associates to a c-Cbl/Crk-II/Grb2 complex via its SH2 domains It has been reported that, once phosphorylated under antigen ligation in B cells or in TCR activated Jurkat T cell line, c-Cbl could bind to the PI 3-kinase (Kim et al., 1995; . To ascertain whether cCbl could also associate with PI 3-kinase upon CSF-1 stimulation in c-FmsCHO cells, we measured the PIkinase activity present in c-Cbl, PY or c-Fms immunopellets and resolved the [g-32 P] ATP incorporated into PI-phosphate by thin layer chromatography. As shown in Figure 4a , in CSF-1 activated lysates we observed an increase in PI-kinase activity associated to CSF-1R and c-Cbl immunoprecipitates as compared to basal condition. Both PI 3-and PI 4-kinase activities have been reported to interact with tyrosine phosphorylated substrates (Prasad et al., 1993) . To precise the nature of the PI-kinase associated to c-Cbl, the kinase assay was performed in presence of wortmannin, a PI 3-kinase speci®c covalent inhibitor (Wymann et al., 1996) . Under these conditions, we observed a 90% decrease in the PI-kinase activity associated with c-Cbl, indicating that c-Cbl was essentially associated to PI 3-kinase. PI 3-kinase has been demonstrated to interact with tyrosine phosphorylated proteins through the two SH2 domains of the p85 regulatory subunit (Lamothe et al., 1995) . To further delineate the role of the two SH2 domains in the interaction of the PI 3-kinase with c-Cbl, immunoprecipitation of c-Cbl was performed in the presence of recombinant GST fusion protein coupled either to the N-terminal or the Cterminal SH2 domain of the p85 subunit of the PI 3-kinase simultaneously (GST-p85 N+C SH2), followed by the PI 3-kinase assay. As shown in Figure 4a , 100% of the c-Cbl-bound PI 3-kinase activity was displaced, while each of the SH2 domains taken independently only partially inhibited the Cbl-PI 3-kinase interaction (data not shown). This strongly suggests that both SH2 domains were engaged during the recruitment of p85 PI 3-kinase to c-Cbl. (7) or subjected (+) to a preclearing procedure using anti-c-Cbl antibodies, then supernatants were immunoprecipitated with anti-Crk-II or anti-Grb2 antibodies. The presence of associated PI 3-kinase activity was detected by incubation with micellar phosphatidylinositol and [g-32 P]ATP as described in Materials and methods. Samples were extracted with chloroform/ methanol, separated by thin-layer chromatography and autoradiographed. The spots corresponding to PI phosphorylated products, representative of three independent experimentations, were quanti®ed with GS-525 Molecular Imaging System (Biorad)
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At that point our data indicate that upon CSF-1 stimulation, (1) Cbl nucleates the formation of a CSF-1R/Grb2/c-Cbl/Crk-II complex and (2) it interacts with PI 3-kinase. We explored the possibility that PI 3-kinase was also a partner of this multiprotein complex. Therefore, we immunoprecipitated Grb2 and Crk-II from unstimulated and CSF-1 stimulated c-FmsCHO cell lysates and measured the PI 3-kinase activity associated by an in vitro kinase assay. As shown in Figure 4b , PI 3-kinase activity associated equally to Crk-II and Grb2 upon CSF-1 stimulation, Interestingly, when lysates were subjected to a preclearing procedure using anti-c-Cbl antibodies, the CSF-1 stimulated PI 3-kinase activity associated to Crk-II and Grb2 immunoprecipitates was diminished by 95% and 75% respectively, while under these conditions the basal level of PI 3-kinase activity was not modi®ed. These results suggest that a substantial amount of PI 3-kinase did interact with the c-Cbl/Crk/Grb2 complex.
Discussion
To study CSF-1 signaling we used c-Fms stably transfected CHO cells (c-FmsCHO) which express the CSF-1R at a level sucient to promote the growth of these cells in the presence of CSF-1 (data not shown). In our system, the product of the proto-oncogene c-cbl was found to be strongly phosphorylated on tyrosine residues in response to CSF-1, whereas a small amount of c-Cbl was phosphorylated on basal condition. Phosphorylation of total c-Cbl occurred rapidly (1 min) following exposure of c-FmsCHO cells to CSF-1 and then remained stable for at least 15 min before slowly decreasing. These data are in agreement with the CSF-1-dependent tyrosine phosphorylation of c-Cbl observed in the murine macrophage cell lines Bac1.2F5 (Wang et al., 1996) and P388D1 . Since a physical association of c-Cbl with the CSF-1R has been proposed (Wang et al., 1996) , we wanted to further delineate the role that c-Cbl phosphorylation might play in CSF-1 signaling pathways. The relationships between c-Cbl and the CSF-1R as well as various cellular transducing proteins were examined. c-Cbl shares a proline-rich domain which can interact with SH3 domain containing proteins and a variety of consensus phosphorylation sites, which once phosphorylated, could serve as docking sites for SH2-domain containing transducing molecules. This structure is very similar to the one exhibited by the Insulin Receptor Substrate-1 (IRS-1), a p185 kDa prominent cytoplasmic substrate of the InsulinReceptor (IR), Insulin like Growth Factor-Receptor (IGF-1R) and several cytokine receptors including interleukin (IL)-4 and IL-13 receptors (Schnyder et al., 1996) . IRS-1 was found to form multimolecular complexes with the regulatory subunit of PI 3-kinase (Backer et al., 1993) , SH-PTP2 (Kuhne et al., 1994) , Nck (Lee et al., 1993) , Grb2 (Pruett et al., 1995) and Fyn (Sun et al., 1996) . Even though c-Cbl has also been shown to associate with a variety of transduction proteins, data supporting the formation of multimolecular complexes analogous to those observed with IRS-1 remained elusive.
Activation of PI 3-kinase is the most common early event triggered by receptor tyrosine kinases (e.g. EGFR, PDGFR, HGFR, erbB-2, CSF-1R) as well as non-receptor protein tyrosine kinases (e.g. Src family kinases) (Karnitz et al., 1994; Liu et al., 1993; Taichman et al., 1993; Wai-Mun Lee, 1992) . In the case of human CSF-1R, the speci®c docking site for PI 3-kinase has been located on Tyr 723 (Tyr 721 for murine) (Van Der Geer and Hunter, 1993) . Exposure of c-FmsCHO cells to CSF-1 induced an increase in a PI kinase activity associated to c-Cb1 immunopellets. This activity likely corresponded to a PI 3-kinase activity as evidenced by the inhibitory eect of wortmannin (a speci®c PI 3-kinase inhibitor) when added to the PI-kinase assay (Wymann et al., 1996) . This observation is in agreement with previous reports (Kim et al., 1995; . c-Cbl possesses two consensus Tyr-X-XMet including Tyr 371 and Tyr 731 which can be involved in the interactions with the SH2 domains of the p85 kDa regulatory subunit of the PI 3-kinase. Besides its SH2 domains, the p85 kDa subunit also possesses proline-rich regions which could promote the interaction of PI 3-kinase with SH3 domain containing proteins. To investigate the way PI 3-kinase interacted with c-Cb1, we used GST fusion proteins coupled to either N-SH2 or C-SH2 domains of the p85 subunit of the PI 3-kinase. When GST-p85 N SH2 and GST-p85 C SH2 fusion proteins were added simultaneously to the immunoprecipitation assay, the c-Cbl-bound PI 3-kinase activity was totally displaced, while addition of only one type of SH2 recombinant protein resulted only in a partial inhibition (data not shown). These data suggested that the two p85-SH2 domains participate in combination to the maximal association of PI 3-kinase with c-Cbl.
Crk-II is an adapter protein carrying one SH2 domain and two SH3 domains that can bind to a variety of signaling proteins (Beitner-Johnson and LeRoith, 1995; Birge et al., 1992; Buday et al., 1996; Feller et al., 1995; Hempstead et al., 1994; Ribon and Saltiel, 1996; Tanaka et al., 1994) . Here, we provide evidence that Crk-II interacts with c-Cbl upon CSF-1 stimulation following a time course compatible with c-Cbl phosphorylation. Crk-SH2 or SH3-recombinant proteins were used to determine the nature of the Crk-II/c-Cbl interaction, since c-Cbl possesses both a proline-rich region and the P-Tyr-X-X-Pro consensus sequence which could potentially interact with the Crk-SH3 and the Crk-SH2 domain respectively. Only the GST-Crk-SH2 interacted with c-Cbl whereas GST-Crk-SH3 failed to do so, thus indicating that Crk-II associated with phosphorylated c-Cb1 exclusively through its SH2 domain. Besides this interaction was not impaired by a previous treatment of cell lysates with SDS, indicating that c-Cbl interacted directly with Crk-II.
In addition, CSR-1R was present in the GST-Crk-SH2 precipitates. These results led us to the puzzling conclusion that Crk-II could interact with both CSF-1R and c-Cb1 through its unique SH2 domain. This can be interpreted in two ways : (1) Crk-II binds directly and independently to the activated CSF1-R or phosphotyrosyl-c-Cbl, in an exclusive manner, or (2) Crk-II forms a complex with c-Cbl and PI 3-kinase which interacts with the CSF-1R. In this case one should expect the involvement of an additional adapter protein, since both PI 3-kinase and Crk-II were shown to have their SH2 domains engaged in their respective interaction with tyrosine phosphorylated c-Cbl. In this regard, Grb2 appeared as a good candidate able to connect the multimolecular complex nucleated by c-Cbl, since (1) Grb2 and c-Cbl have been shown to form stable complexes in HL-60 and Jurkat cells, via the Nterminal SH3 domain of Grb2 and the proline-rich motif of the C-terminus of c-Cbl (Donovan et al., 1994; Rivero-Lezcano et al., 1994) and (2) human CSF-1R harbors a docking motif for Grb2 SH2 domain on Tyr 699 (Tyr 697 for murine) (Van Der Geer and Hunter, 1993) . In fact, when endogenous Grb2 was immunoprecipitated from c-FmsCHO cells, a signi®cant amount of c-Cbl was recruited in the pellet, even in the absence of CSF-1, indicating that Grb2 was constitutively associated with c-Cbl, in agreement with a previous report (Odai et al., 1995) . CSF-1R was also found to interact with Grb2 only in the presence of CSF-1, thus supporting the idea that Grb2 could connect c-Cbl to the autophosphorylated CSF-1R. It is noteworthy that the phosphorylation time-course of the whole c-Cb1 molecules was dierent from that observed for the Grb2-associated subpopulation of c-Cbl. This data underscores the fact that the c-Cbl molecules that are susceptible to interact with CSF-1R (via Grb2) has a dierent fate than the rest of the cytosolic molecules. When Crk-SH2 matrix was incubated with CSF-1-stimulated c-FmsCHO cell lysates, CSF-1R, c-Cbl and Grb2 were recovered in the pellet, con®rming that CSF-1 induced the formation of a multimolecular complex. When cell lysates were pretreated with SDS, Grb2 failed to interact with the c-Cbl/Crk-II complex, consistent with its expected association with c-Cbl via a SH3/ proline-rich interaction. Interestingly, under these conditions, disruption of the Grb2/c-Cbl association disconnected CSF-1R from the complex nucleated by cCbl.
To precise whether PI 3-kinase also participate to the c-Cbl-nucleated protein complex, we ®rst veri®ed that a signi®cant amount of PI 3-kinase activity was present in the anti-Crk-II and anti-Grb2 precipitates. Furthermore when lysates were precleared with anti-cCbl antibodies, 95% and 75% of the CSF-1-induced PI 3-kinase activity found respectively in the anti-Crk-II and anti-Grb2 immunoprecipitates was lost. Collectively, these data support the idea that, under CSF-1 stimulation, a substantial amount of PI 3-kinase associates to a multiprotein complex where Cb1 plays the role of a core protein interacting independently with Crk, Grb2 and PI 3-kinase. Other complexes containing c-Cbl have been previously reported to build-up upon BCR (Smit et al., 1996) or EGFR stimulation. Nevertheless, the composition of these complexes is dierent from that obtained here upon CSF-1 stimulation, suggesting that each receptor organizes its own c-Cbl nucleated complex.
Taken together, our data support the model depicted in Figure 5 where, upon CSF-1 stimulation, a c-Cbl molecule permanently associated to Grb2 through its SH3 domain, undergoes a tyrosine phosphorylation that allows its interaction with PI 3-kinase and Crk-II via their SH2 domains. The complex nucleated by cCbl associates through the unoccupied SH2 domain of Grb2 to the phosphorylated Tyr 699 of the CSF-1R. This model is consistent with a recent report showing that under CSF-1 stimulation, c-Cbl translocates from the cytoplasm to the membrane (Wang et al., 1996) . This type of behavior ®ts with the emerging concept of anchoring proteins (Faux and Scott, 1996) , a status that c-Cbl might share with IRS-1. But, in contrast with IRS-1, which interacts directly via its phosphotyrosine binding (PTB) domain to consensus sites of the insulin or IGF-1 receptors (Craparo et al., 1995; O'Neill et al., 1994) , we provide evidence that c-Cbl interacts indirectly with CSF-1R via Grb2. More studies are necessary to understand the physiological signi®cance of the membrane targeting of such In this regard, it appears of particular interest to understand the respective role that the two modes of recruitment of PI 3-kinase might play in the signaling cascade triggered by CSF-1R.
Materials and methods

Reagents
Ham's F12, penicillin, streptomycin, G418 and Fetal Calf Serum (FCS) were from Gibco BRL (Cergy Pontoise, France). Biotinylated monoclonal anti-PY (clone 4G10) and anti-c-Fms antibodies were purchased from UBI (Euromedex, Souelweyersheim, France), anti-Cbl (SC#170), anti-Grb2 (SC#255) and anti-Crk-II (SC#289) antibodies from Santa-Cruz Biotechnology (Tebu, Le Perray en Yvelines, France), Streptavidin-Horse Radish Peroxydase (HRP) conjugated from Amersham (Les Ulis, France), anti-mouse and anti-rabbit HRP-conjugated antibodies from Dako (Dako, Trappes, France). All other reagents unless speci®ed were from Sigma (St Quentin Fallavier, France).
Cloning of the CSF-1R cDNA
The human CSF-1R cDNA was isolated by screening of a lgt11 placental cDNA library (Clontech Laboratory Inc, Palo Alto, USA) with a 1.1 kb murine c-fms insert. We obtained one 4.3 kb recombinant phage containing the 3.2 kb c-fms open reading frame. The cDNA obtained was subcloned into the pECE eucaryotic expression vector (pECEc-fms) and entirely sequenced.
Cell culture and transfection
CHO cells were grown in Ham's F12 medium supplemented with 100 units/ml penicillin, 100 mg/ml streptomycin and 10% heat-inactivated FCS. Transfections of CHO cells were carried out using the calcium phosphate precipitation procedure (Sambrook et al., 1989) with 10 mg of pECEcfms and 1 mg of pSV2neo prepared by Qiagen Maxi-preps (Coger, Paris, France). After a 24 h recovery period, transfectants were selected with 500 mg/ml active G418 for 2 weeks. Clones were isolated and screened for CSF-1R expression by 125 I-labeled CSF-1 binding experiments as described previously (Stanley and Guilbert, 1981) . Before CSF-1 activation, c-FmsCHO cells were serum starved overnight in Ham's F12 medium containing 20 mM HEPES and 0.1% Bovine Serum Albumin (BSA).
Activation of c-fms expressing CHO cells and immunoprecipitations
Serum-starved c-FmsCHO cells were stimulated with 0.6 nM CSF-1 for the indicated times at 378C, washed twice with icecold PBS and the reactions were stopped by cell solubilization in ice-cold Lysis Buer (LB : 50 mM Tris/HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml leupeptin, 1 mM pepstatine A and 1% Nonidet P40 (NP40)) for 30 min at 48C. Lysates were cleared by centrifugation at 10 000 g for 10 min at 48C. Cellular proteins were quanti®ed by the Biorad DC-protein assay (Biorad, Ivry sur Seine, France) using BSA as standard prior to immunoprecipitation or binding to GST fusion proteins. Cleared whole lysates (500 mg, approximately 5610 6 cells/conditions) were subjected to immunoprecipitation with 0.5 mg of the indicated antibodies for 2 h at 48C. The immunocomplexes were precipitated by incubation with protein A-Sepharose (Pharmacia Biotech SA, Orsay, France) for 1 h at 48C and washed 5 times with LB.
Preclearing procedures were performed by two rounds of immunoprecipitations using 0.5 mg of the indicated antibodies.
Precipitation using GST fusion protein
The Glutathione S-Transferase (GST) fusion proteins were anity-puri®ed on glutathione-Sepharose beads (Pharmacia Biotech SA, Orsay, France) using a Triton X-100-soluble fraction of the isopropyl-1-b-g-galactopyranosideinduced Escherichia coli (BL21E3 strain). Puri®ed GST fusion proteins (3 ± 30 mg) immobilized to glutathioneSepharose beads were incubated with 500 mg of cell lysates for 1 h at 48C and washed as previously described (RamosMorales et al., 1994) .
For double precipitation experiments, GST bound proteins were eluted in LB containing 10 mM fresh Glutathione, prior to immunoprecipitation with anti-c-Fms antibodies, and washed as described above.
When described, cells were lysed in LB containing 1% SDS, heated for 5 min at 1008C, diluted tenfold in LB and precipitated with GST-Crk-SH2 fusion protein as described above.
Western blotting
GST-bound proteins, immunoprecipitated proteins or cell lysates were boiled in the presence of 3% SDS and 0.7 M 2-mercaptoethanol prior to being separated by 8.5% SDS ± PAGE and transferred onto Immobilon-P membranes (Millipore, St Quentin en Yvelines, France) as previously described (Schmid-Antomarchi et al., 1995) . Immunoblots were incubated overnight at 48C with either biotinylated anti-PY (0.25 mg/ml) or the indicated monoclonal or polyclonal speci®c antibodies (0.1 mg/ml). After three washes with TNN buer (10 mM Tris/HCl pH 7.4, 0.15 M NaCl, 1% NP40), the primary biotinylated, polyclonal or monoclonal antibodies were detected with HRP conjugated-streptavidin (1 : 10 000, -anti-rabbit (1 : 10 000) or -anti-mouse (1 : 7000) respectively and visualized by Enhanced Chemiluminescence detection system with autoradiography hyper®lms MP (Amersham). When indicated, the immunoblots were stripped for 30 min by incubating at 508C in 67 mM Tris/HCl pH 6.7, 2% SDS, 100 mM 2-mercaptoethanol and reprobed following the protocol described above.
PI -kinase assay
Cleared whole lysates from unstimulated or CSF-1 stimulated cells as described above (250 mg) were precipitated with either 0.2 mg of anti-c-Fms, anti-Cbl or antiCrk-II antibodies. When indicated, wortmannin was added at the ®nal concentration of 5 nM during the kinase assay. For c-Cbl preclearing, the lysates were deprived from 95% of the c-Cbl content by two runs of immunoprecipitations as described above. Immunopellets were treated and subjected to PI -kinase assay as previously described (Schmid-Antomarchi et al., 1995) . Phosphorylated reaction products were extracted by methanol-chloroform and then separated by thin layer chromatography onto LK6D silicagel plates. The spots corresponding to the phosphorylated products were quanti®ed with the GS-525 Molecular Imaging System (Biorad).
